Emcure Pharma Extends Winning Streak; Gains Over 12% in 3 Sessions

Emcure Pharmaceuticals’

share price surged sharply on Monday, rising as much as 8.13% intraday before settling with a 7.12% gain. This marks the stock’s third consecutive winning session, with a total rally of over 12% across the last three trading days. The strong upward movement in the stock came after the company announced the acquisition of the remaining 20.42% stake in Zuventus Healthcare, making it a wholly owned subsidiary. The stock showed robust momentum throughout the session, reflecting active participation from market participants following the announcement. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.